Cargando…
Primary non-Hodgkin lymphoma of the prostate: a case report
This report is of a 68-year-old male patient with a three-year history of severe, progressive, low urinary tract symptoms (LUTS) with a score of 20 points on the International Symptom Scale. The patient received alpha-1-blocker therapy without adequate response. Transurethral resection of the prosta...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739870/ https://www.ncbi.nlm.nih.gov/pubmed/29290758 http://dx.doi.org/10.3332/ecancer.2017.789 |
_version_ | 1783287959575855104 |
---|---|
author | Martín, Oscar D Wadskier, Luis Alfredo Quiroz, Yesica Bravo, Heilen P Cacciamani, Giovanni Umaña, Paola Medina, Luis |
author_facet | Martín, Oscar D Wadskier, Luis Alfredo Quiroz, Yesica Bravo, Heilen P Cacciamani, Giovanni Umaña, Paola Medina, Luis |
author_sort | Martín, Oscar D |
collection | PubMed |
description | This report is of a 68-year-old male patient with a three-year history of severe, progressive, low urinary tract symptoms (LUTS) with a score of 20 points on the International Symptom Scale. The patient received alpha-1-blocker therapy without adequate response. Transurethral resection of the prostate was performed, and the anatomopathological report indicated the presence of a haematolymphoid small-cell neoplasia and glandulostromal prostatic hyperplasia. Posterior immunohistochemistry evaluation reported an extra-nodal marginal zone-B lymphoma non-Hodgkin lymphoma. The patient was followed up for five years by the urology and oncology departments. In the fourth year of follow-up, the patient had B symptoms (fever, night sweats and weight loss). At the same time, laboratory tests showed haemolytic anaemia; then a new bone marrow biopsy was carried out. The histopathological specimen showed six lymphoid aggregates, constituted by a B-cell population with intra-trabecular predominance and reactivity for CD20 and BCL-2. New thoracic and abdominal computed tomographies were performed without any findings suggestive of extra-prostatic spreading. Subsequently, a chemotherapy regimen was started on the patient with the following therapeutic scheme: Rituximab 375 mg/m(2) IV per day, cyclophosphamide 750 mg/m(2) IV per day, Vincristine 1.4 mg/m(2) IV dose per day and Prednisone 40 mg/m(2) on days 1–5 (R-CVP scheme) for 21 days, until he completed six cycles. No signs, symptoms or progression have been recorded. |
format | Online Article Text |
id | pubmed-5739870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-57398702017-12-29 Primary non-Hodgkin lymphoma of the prostate: a case report Martín, Oscar D Wadskier, Luis Alfredo Quiroz, Yesica Bravo, Heilen P Cacciamani, Giovanni Umaña, Paola Medina, Luis Ecancermedicalscience Case Report This report is of a 68-year-old male patient with a three-year history of severe, progressive, low urinary tract symptoms (LUTS) with a score of 20 points on the International Symptom Scale. The patient received alpha-1-blocker therapy without adequate response. Transurethral resection of the prostate was performed, and the anatomopathological report indicated the presence of a haematolymphoid small-cell neoplasia and glandulostromal prostatic hyperplasia. Posterior immunohistochemistry evaluation reported an extra-nodal marginal zone-B lymphoma non-Hodgkin lymphoma. The patient was followed up for five years by the urology and oncology departments. In the fourth year of follow-up, the patient had B symptoms (fever, night sweats and weight loss). At the same time, laboratory tests showed haemolytic anaemia; then a new bone marrow biopsy was carried out. The histopathological specimen showed six lymphoid aggregates, constituted by a B-cell population with intra-trabecular predominance and reactivity for CD20 and BCL-2. New thoracic and abdominal computed tomographies were performed without any findings suggestive of extra-prostatic spreading. Subsequently, a chemotherapy regimen was started on the patient with the following therapeutic scheme: Rituximab 375 mg/m(2) IV per day, cyclophosphamide 750 mg/m(2) IV per day, Vincristine 1.4 mg/m(2) IV dose per day and Prednisone 40 mg/m(2) on days 1–5 (R-CVP scheme) for 21 days, until he completed six cycles. No signs, symptoms or progression have been recorded. Cancer Intelligence 2017-12-12 /pmc/articles/PMC5739870/ /pubmed/29290758 http://dx.doi.org/10.3332/ecancer.2017.789 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Martín, Oscar D Wadskier, Luis Alfredo Quiroz, Yesica Bravo, Heilen P Cacciamani, Giovanni Umaña, Paola Medina, Luis Primary non-Hodgkin lymphoma of the prostate: a case report |
title | Primary non-Hodgkin lymphoma of the prostate: a case report |
title_full | Primary non-Hodgkin lymphoma of the prostate: a case report |
title_fullStr | Primary non-Hodgkin lymphoma of the prostate: a case report |
title_full_unstemmed | Primary non-Hodgkin lymphoma of the prostate: a case report |
title_short | Primary non-Hodgkin lymphoma of the prostate: a case report |
title_sort | primary non-hodgkin lymphoma of the prostate: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739870/ https://www.ncbi.nlm.nih.gov/pubmed/29290758 http://dx.doi.org/10.3332/ecancer.2017.789 |
work_keys_str_mv | AT martinoscard primarynonhodgkinlymphomaoftheprostateacasereport AT wadskierluisalfredo primarynonhodgkinlymphomaoftheprostateacasereport AT quirozyesica primarynonhodgkinlymphomaoftheprostateacasereport AT bravoheilenp primarynonhodgkinlymphomaoftheprostateacasereport AT cacciamanigiovanni primarynonhodgkinlymphomaoftheprostateacasereport AT umanapaola primarynonhodgkinlymphomaoftheprostateacasereport AT medinaluis primarynonhodgkinlymphomaoftheprostateacasereport |